Department of Anesthesiology, Lu'an Affiliated Hospital of Anhui Medical University, No.21 West Wanxi Road, Jinan District, Lu'an, 237000, Anhui, China.
Department of Anesthesiology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian, China.
BMC Anesthesiol. 2022 Sep 1;22(1):276. doi: 10.1186/s12871-022-01819-x.
Postoperative sore throat (POST) is one of the main adverse postoperative outcome after tracheal intubation using double-lumen endobronchial tubes (DLTs). The aim of this study was to investigate the effectiveness and safety of ultrasound (US)-guided block of the internal branch of the superior laryngeal nerve (iSLN) for alleviating POST after intubation of DLTs.
Patients undergoing thoracic surgery between August 2019 and August 2021 were randomized into two groups depending on whether they received US-guided iSLN block immediately after the operation. In the control group, the patients underwent a thoracic surgery under general anesthesia (GA) with DLTs without any special treatment, while the patients in the experimental group received US-guided iSLN block bilaterally with 2 ml of 0.25% ropivacaine on either side immediately after the operation. The primary outcome was the grading of sore throat at three-time points after the operation, i.e., immediate extubation, 2 h after extubation, and 24 h after extubation. Secondary outcomes included the rate of nausea and vomiting, hoarseness, dyspnea, and choking cough after swallowing saliva at 2 h after extubation.
The incidence and severity of sore throat were significantly lower in the experimental group than the control group at all time intervals (all P < 0.01). The rate of nausea and vomiting, hoarseness, dyspnea, and choking cough after swallow saliva at 2 h after extubation had no statistical difference (all P > 0.05).
The use of US-guided iSLN block can be effectively and safely applied to relieve POST after intubation of DLTs on thoracic surgery.
The study protocol was registered at the Chinese Clinical Trial Registry ( http://www.chictr.org.cn , NO. ChiCTR2000032188, 22/04/2020).
术后咽喉痛(POST)是双腔支气管内导管(DLT)插管后主要的不良术后结果之一。本研究旨在探讨超声(US)引导下喉上神经内支(iSLN)阻滞对减轻 DLT 插管后 POST 的效果和安全性。
2019 年 8 月至 2021 年 8 月期间行胸部手术的患者,根据术后是否立即接受 US 引导的 iSLN 阻滞,随机分为两组。对照组患者在全身麻醉(GA)下接受胸部手术,插入 DLT,无特殊治疗,而实验组患者在术后立即双侧 US 引导 iSLN 阻滞,每侧 2ml 0.25%罗哌卡因。主要结局为术后 3 个时间点(即拔管即刻、拔管后 2 小时和拔管后 24 小时)的咽喉痛分级。次要结局包括拔管后 2 小时恶心呕吐、声音嘶哑、呼吸困难和吞咽唾液时呛咳的发生率。
实验组在所有时间点的咽喉痛发生率和严重程度均显著低于对照组(均 P<0.01)。拔管后 2 小时恶心呕吐、声音嘶哑、呼吸困难和吞咽唾液时呛咳的发生率无统计学差异(均 P>0.05)。
超声引导下 iSLN 阻滞可有效、安全地应用于减轻胸部手术 DLT 插管后 POST。
研究方案在中国临床试验注册中心(http://www.chictr.org.cn,注册号 ChiCTR2000032188,2020 年 4 月 22 日)注册。